Skip to content

Identifying the relationship between biochemical markers and wound healing in chronic venous leg ulcers treated with compression therapy

Identifying relationships between compression type, biochemical markers and wound healing outcomes in patients with venous leg ulcers: Randomised controlled trial.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611000224921
Enrollment
103
Registered
2011-03-01
Start date
2006-09-15
Completion date
2009-01-20
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This project aims to identify the relationship between biochemical markers in wound fluid and wound healing in chronic venous leg ulcers being treated with compression therapy. A randomised controlled trial will determine the effect of high level compression on wound fluid composition and wound healing in comparison to low level compression therapy. Identification of biochemical markers directly associated with improved healing will provide important new information for health care professionals on the biological processes underlying wound healing during compression. The overall aim is to gain a better understanding of the wound healing process and to utilise this knowledge to develop improved techniques to increase healing rates of leg ulcers, a significant cause of chronic ill-health for older people.

Interventions

Group 1: Four layer compression bandage system - Profore, applied once per week for the 24 weeks of the study (or until healed, whichever occurs sooner), as per producer's instructions and patient's ankle circumference e.g. Less than 18cm: 2 or more Orthopaedic wool, 1 crepe, 1 Class 3a bandage, 1 Cohesive bandage; 18-25cm: 1 Orthopaedic wool, 1 Crepe, 1 Class 3a bandage, 1 Cohesive bandage; 25-30cm: 1 Orthopaedic wool, 1 Class 3c, 1 Cohesive bandage; Greater than 30cm: 1 Orthopaedic wool

Group 1: Four layer compression bandage system - Profore, applied once per week for the 24 weeks of the study (or until healed, whichever occurs sooner), as per producer's instructions and patient's ankle circumference e.g. Less than 18cm: 2 or more Orthopaedic wool, 1 crepe, 1 Class 3a bandage, 1 Cohesive bandage; 18-25cm: 1 Orthopaedic wool, 1 Crepe, 1 Class 3a bandage, 1 Cohesive bandage; 25-30cm: 1 Orthopaedic wool, 1 Class 3c, 1 Cohesive bandage; Greater than 30cm: 1 Orthopaedic wool, 1 Class 3a, 1 Class 3c, 1 Cohesive.

Sponsors

Prof. Helen Edwards
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

- Clients with leg ulcers of venous aetiology - Ankle Brachial Pressure Index >0.8 and <1.3 - Ulcer size between 1cm2 – 30cm2

Exclusion criteria

- Clients unable to mobilise at all i.e. completely bed or wheelchair bound - Ankle Brachial Pressure Index <0.8 or >1.3 - Presence of clinical signs of infection on admission - Clients with cognitive impairment

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026